India · Delayed Price · Currency is INR GlaxoSmithKline Pharmaceuticals Company Description
GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally.
The company offers adult and pediatric vaccines, such as Shingrix, Havrix, Fluarix Tetra, Varilrix, Infanrix Hexa, Boostrix, Synflorix, Menveo, and Priorix.
It also provides respiratory specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; Trelegy Ellipta for treating chronic obstructive pulmonary disease; and Seretide.
In addition, the company offers general medicines, including Augmentin, an oral antibiotic for respiratory tract infections, surgical prophylaxis, dental infections and skin infections; Ceftum, an anti-infective medicine; CobadexCZS and CCM, for mineral, vitamins, and nutrition; Calpol and Calpo T, for pain management; Eltroxin for hypothyroidism; and Neosporin, Betnovate, T-bact, Physiogel, Tenovate, and Flutivate medicines for dermatology.
Further, it provides oncology medicines, including Jemperli and Zejula. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001.
The company was incorporated in 1924 and is based in Mumbai, India. GlaxoSmithKline Pharmaceuticals Limited operates as a subsidiary of GSK plc.
| Country | India |
| Founded | 1924 |
| Industry | Pharmaceutical Preparations |
| Employees | 3,103 |
| CEO | Bhushan Akshikar |
Contact Details
Address: GSK House Mumbai, Maharashtra 400030 India | |
| Phone | 91 22 2495 9595 |
| Website | india-pharma.gsk.com |
Stock Details
| Ticker Symbol | 500660 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Bhushan Akshikar | Chief Executive Officer |
| Ronojit Biswas | Chief Financial Officer |